Zacks Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $64M | Buy |
2,658,388
+2,872
| +0.1% | +$75.1K | 0.46% | 65 |
|
|
2026
Q1 | $74.6M | Buy |
2,655,516
+141,613
| +6% | +$3.77M | 0.6% | 47 |
|
|
2025
Q4 | $62.6M | Sell |
2,513,903
-185,161
| -7% | -$4.67M | 0.49% | 56 |
|
|
2025
Q3 | $68.8M | Buy |
2,699,064
+41,437
| +2% | +$1.02M | 0.55% | 50 |
|
|
2025
Q2 | $64.4M | Buy |
2,657,627
+15,425
| +0.6% | +$360K | 0.55% | 51 |
|
|
2025
Q1 | $67M | Buy |
2,642,202
+206,082
| +8% | +$5.39M | 0.63% | 46 |
|
|
2024
Q4 | $64.6M | Buy |
2,436,120
+46,982
| +2% | +$1.27M | 0.6% | 49 |
|
|
2024
Q3 | $69.1M | Buy |
2,389,138
+235,243
| +11% | +$6.86M | 0.6% | 48 |
|
|
2024
Q2 | $60.3M | Buy |
2,153,895
+61,200
| +3% | +$1.68M | 0.68% | 36 |
|
|
2024
Q1 | $58.1M | Buy |
2,092,695
+123,684
| +6% | +$3.43M | 0.62% | 44 |
|
|
2023
Q4 | $56.7M | Sell |
1,969,011
-464,694
| -19% | -$14M | 0.7% | 41 |
|
|
2023
Q3 | $80.7M | Sell |
2,433,705
-10,739
| -0.4% | -$380K | 1.05% | 25 |
|
|
2023
Q2 | $89.7M | Buy |
2,444,444
+21,203
| +0.9% | +$825K | 1.13% | 22 |
|
|
2023
Q1 | $98.9M | Buy |
2,423,241
+12,688
| +0.5% | +$548K | 1.33% | 16 |
|
|
2022
Q4 | $124M | Buy |
2,410,553
+92,749
| +4% | +$4.45M | 1.72% | 12 |
|
|
2022
Q3 | $101M | Buy |
2,317,804
+133,641
| +6% | +$6.49M | 1.62% | 12 |
|
|
2022
Q2 | $115M | Buy |
2,184,163
+182,883
| +9% | +$9.32M | 1.75% | 7 |
|
|
2022
Q1 | $104M | Buy |
2,001,280
+91,496
| +5% | +$4.75M | 1.44% | 13 |
|
|
2021
Q4 | $113M | Buy |
1,909,784
+142,128
| +8% | +$7.04M | 1.59% | 7 |
|
|
2021
Q3 | $76M | Buy |
1,767,656
+51,101
| +3% | +$2.26M | 1.2% | 17 |
|
|
2021
Q2 | $67.2M | Buy |
1,716,555
+129,863
| +8% | +$5.05M | 1.09% | 21 |
|
|
2021
Q1 | $57.5M | Sell |
1,586,692
-160,595
| -9% | -$5.7M | 1.02% | 24 |
|
|
2020
Q4 | $64.3M | Sell |
1,747,287
-279,601
| -14% | -$10.3M | 1.19% | 15 |
|
|
2020
Q3 | $70.6M | Buy |
2,026,888
+80,061
| +4% | +$2.81M | 1.43% | 13 |
|
|
2020
Q2 | $60.4M | Sell |
1,946,827
-84,782
| -4% | -$2.88M | 1.33% | 18 |
|
|
2020
Q1 | $62.9M | Buy |
2,031,609
+4,341
| +0.2% | +$148K | 1.54% | 14 |
|
|
2019
Q4 | $75.4M | Sell |
2,027,268
-11,634
| -0.6% | -$414K | 1.41% | 16 |
|
|
2019
Q3 | $69.5M | Buy |
2,038,902
+48,890
| +2% | +$1.78M | 1.39% | 16 |
|
|
2019
Q2 | $81.8M | Buy |
1,990,012
+20,902
| +1% | +$830K | 1.68% | 10 |
|
|
2019
Q1 | $79.3M | Sell |
1,969,110
-217,370
| -10% | -$8.71M | 1.7% | 9 |
|
|
2018
Q4 | $90.5M | Sell |
2,186,480
-163,737
| -7% | -$6.8M | 2.18% | 4 |
|
|
2018
Q3 | $98.3M | Buy |
2,350,217
+145,550
| +7% | +$5.6M | 2.05% | 5 |
|
|
2018
Q2 | $75.9M | Buy |
2,204,667
+21,555
| +1% | +$737K | 1.65% | 8 |
|
|
2018
Q1 | $73.5M | Buy |
2,183,112
+67,039
| +3% | +$2.3M | 1.63% | 8 |
|
|
2017
Q4 | $72.7M | Buy |
2,116,073
+38,879
| +2% | +$1.33M | 1.59% | 9 |
|
|
2017
Q3 | $70.4M | Buy |
2,077,194
+24,397
| +1% | +$784K | 1.65% | 8 |
|
|
2017
Q2 | $65.4M | Sell |
2,052,797
-48,050
| -2% | -$1.52M | 1.62% | 8 |
|
|
2017
Q1 | $68.2M | Buy |
2,100,847
+136,212
| +7% | +$4.29M | 1.73% | 8 |
|
|
2016
Q4 | $60.5M | Sell |
1,964,635
-6,304
| -0.3% | -$192K | 1.74% | 8 |
|
|
2016
Q3 | $63.3M | Buy |
1,970,939
+147,391
| +8% | +$4.93M | 1.79% | 9 |
|
|
2016
Q2 | $60.9M | Buy |
1,823,548
+38,064
| +2% | +$1.21M | 1.86% | 5 |
|
|
2016
Q1 | $50.2M | Sell |
1,785,484
-55,738
| -3% | -$1.59M | 1.59% | 10 |
|
|
2015
Q4 | $56.4M | Sell |
1,841,222
-18,979
| -1% | -$597K | 1.84% | 5 |
|
|
2015
Q3 | $55.4M | Buy |
1,860,201
+104,854
| +6% | +$3.36M | 1.93% | 4 |
|
|
2015
Q2 | $55.8M | Sell |
1,755,347
-12,951
| -0.7% | -$422K | 1.77% | 4 |
|
|
2015
Q1 | $58.4M | Buy |
1,768,298
+45,522
| +3% | +$1.45M | 1.85% | 4 |
|
|
2014
Q4 | $50.9M | Buy |
1,722,776
+29,754
| +2% | +$853K | 1.65% | 3 |
|
|
2014
Q3 | $47.4M | Buy |
1,693,022
+62,056
| +4% | +$1.74M | 1.65% | 4 |
|
|
2014
Q2 | $46M | Sell |
1,630,966
-102,024
| -6% | -$2.91M | 1.63% | 5 |
|
|
2014
Q1 | $52.8M | Buy |
1,732,990
+194,206
| +13% | +$5.79M | 1.96% | 1 |
|
|
2013
Q4 | $44.7M | Buy |
1,538,784
+482,357
| +46% | +$14M | 1.76% | 3 |
|
|
2013
Q3 | $28.8M | Buy |
1,056,427
+72,582
| +7% | +$1.97M | 1.24% | 11 |
|
|
2013
Q2 | $26.1M | Buy |
+983,845
| New | +$27.2M | 1.2% | 11 |
|
Other funds holding PFE
Zacks Investment Management's PFE Position: Q2 2026 in Review
Zacks Investment Management increased its Pfizer (PFE) stake by 0.11% in Q2 2026, buying an estimated $75.1K and bringing the position to 2,658,388 shares worth $64M. The position accounts for 0.46% of the portfolio, ranked #65.
Zacks Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $124M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Zacks Investment Management held 2,658,388 shares of Pfizer worth $64M as of Q2 2026.
- Zacks Investment Management bought 2,872 Pfizer shares in Q2 2026, an estimated $75.1K.
- Pfizer made up 0.46% of Zacks Investment Management's portfolio in Q2 2026, its #65 holding.
- Zacks Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Zacks Investment Management's Pfizer position peaked at $124M in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Zacks Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.